EIP Pharma

11 Channing Street
Cambridge
Massachusetts
02138-4713
United States

Tel: 617-868-0510

Email: jalam@eippharma.com

Show jobs for this employer

About EIP Pharma

EIP Pharma, LLC is a private company that has licensed-in and is developing VX-745, a phase 2 clinical-stage oral investigational drug that targets neuro-inflammation, dysfunction of microglia (the major immune-cell in the brain) and the effects of inflammation in the brain on neuronal & synaptic function.
YEAR FOUNDED:
2010
LEADERSHIP:
Founder and CEO: John Alam
Founder: Sylvie Grégoire
CLINICAL TRIAL:
Please click here for clinical trial information.

36 articles about EIP Pharma